OTCMKTS:CHXIF Relay Medical (CHXIF) Stock Price, News & Analysis → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free CHXIF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.18▼$0.1850-Day Range N/A52-Week Range$0.16▼$0.60Volume10,000 shsAverage Volume955 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Relay Medical alerts: Email Address Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> About Relay Medical Stock (OTCMKTS:CHXIF)Relay Medical Corp. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. Its platform technologies include HemoPalm, Pharmatrac, and Osprey. The HemoPalm develops a POCT unit-use cartridge based blood analyzer with full enterprise capabilities. The Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment. The Osprey, commercializes products and services related to the management of decentralized fleets of medical devices and the data streams they produce. The company was founded by James Samsoondar in 2005 and is headquartered in Toronto, Canada.Read More Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> CHXIF Stock News HeadlinesSeptember 13, 2023 | msn.comIn China, a Completely Different Approach to Lowering Healthcare CostsSeptember 6, 2023 | msn.comKilling 'birds': Evolution of Ukrainian battlefield drones manufacturingMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.September 2, 2023 | msn.comHelp rescue colleague from abductors, Ogun doctors beg IGAugust 30, 2023 | msn.comFamily of late swim star Jamie Cail rejects OD ruling, claims she was beaten to deathAugust 30, 2023 | msn.comSwimmer Jamie Cail's death was ruled a drug overdose, but her family says photos of her body shows she was beatenAugust 29, 2023 | msn.comSwimmer Jamie Cail's death was ruled a drug overdose, but her family says a photo of her body shows she was beatenAugust 27, 2023 | msn.comJacksonville shooter named; Prigozhin's death confirmed: Weekend RundownMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.August 26, 2023 | bbc.co.ukHenderson set for Crystal Palace medicalAugust 25, 2023 | bbc.comWest Ham agree deal for KudusAugust 25, 2023 | thetimes.co.ukVictoria Ohuruogu to compete in relay despite anti-doping investigationAugust 18, 2023 | msn.comMaui fires – update: Biden says he doesn’t want to ‘get in the way’ as Hawaii death toll reaches 101August 17, 2023 | msn.comHawaii fire death tolls hits 111 as Maui officials say warning sirens would not have saved lives: Live updatesAugust 17, 2023 | nz.news.yahoo.comMaui wildfire miracle with 60 survivors found in single home as death toll hits 110 – live updatesAugust 17, 2023 | msn.comMaui wildfire miracle with 60 survivors found in home as video shows possible cause – live updatesAugust 15, 2023 | nytimes.comHawaii WildfireBiden Says He Will Travel to HawaiiAugust 14, 2023 | msn.comLahaina blaze now the deadliest in modern U.S. history: RecapAugust 6, 2023 | msn.comAllegations of Phoenix detective’s misconduct come to light in drive-by homicide caseJuly 29, 2023 | msn.comA pandemic-era brainstorm has become 'the highlight of my career,' says CoxHealth VPJuly 29, 2023 | msn.comNew lawsuit against Norton Healthcare claims 15-year-old was denied medical careJuly 28, 2023 | msn.comAstroworld Fest: Houston Police Report Details ‘Carnage’ and ChaosJuly 27, 2023 | msn.comTips and resources for coping with extreme heat in New York, New Jersey, and ConnecticutJuly 27, 2023 | msn.comOfficials caution residents ahead of NYC's first potential heat wave of summer | How to prepareJuly 24, 2023 | finance.yahoo.comViking Energy Announces Notice of Allowance for Additional Patent Covering Transmission Line Ground Fault Prevention SystemsJuly 21, 2023 | msn.comProtesting overhaul, hundreds join growing list of reservists ending volunteer dutyJuly 20, 2023 | msn.com‘Won’t serve dictatorship’: Reservists to suspend volunteer duty over legal shakeupSee More Headlines Receive CHXIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relay Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Oil & Gas Production Sub-IndustryN/A Current SymbolOTCMKTS:CHXIF Previous SymbolOTCMKTS:MNLIF CUSIPN/A CIKN/A WebN/A Phone(647) 872-9982FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Gerard M. EdwardsExec. ChairmanMr. Christopher J. Hopkins CA (Age 55)CPA, MBA, Chief Financial Officer Mr. George S. Langdon (Age 60)Director Mr. Ashwani KaushalConsultantMr. Lahav GilCEO & DirectorKey Competitors180 Life SciencesNASDAQ:ATNFW1933 IndustriesOTCMKTS:TGIFF3SBioOTCMKTS:TRSBF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFView All Competitors This page (OTCMKTS:CHXIF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Medical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
